BioCompounding BioCompounding
  • Home
  • About Us
  • Why BioCompounding
  • Technologies in 5 mins
  • Deep Dives
Subscribe
Deep Dives

A Biotech Growth Stock to Consider For Your Portfolio - Sarepta Therapeutics (NASDAQ: SRPT)

Biocompounding

Biocompounding

Oct 2, 2022 14 min
A Biotech Growth Stock to Consider For Your Portfolio - Sarepta Therapeutics (NASDAQ: SRPT)
Photo by JINZHOU LIN / Unsplash

This post is for subscribers only

Subscribe now

Already have an account? Sign in

Read next

Edwards Lifesciences

Edwards Lifesciences (EW) — From Valve Pioneer to Structural Heart Powerhouse

1. The Premise Today we are going to be looking at a company whose entire existence is concentrated on solving one disease, in one organ, for one population of patients — and which has spent six decades doing so with such singular intensity that it has become genuinely irreplaceable. Edwards Lifesciences
Biocompounding Sep 6, 2026
Intuitive Surgical (ISRG): What Three Years and a New Robot Changed

Intuitive Surgical (ISRG): What Three Years and a New Robot Changed

A Note to Readers When we first wrote about Intuitive Surgical, the company was the unambiguous, effectively unchallenged leader of a market it had created. The investment thesis was compelling but simple: a dominant installed base, an annuity stream of instruments and service revenue, and a regulatory and switching-cost
Biocompounding Jun 14, 2026
Stryker Corporation (SYK): Engineering the Future of Healthcare

Stryker Corporation (SYK): Engineering the Future of Healthcare

1. The Premise: A MedTech Compounder with Two Compounding Engines The medtech industry is undergoing a structural transformation unlike any in its history. Three forces are converging simultaneously: the most powerful demographic tailwind in recorded medicine — an ageing global population whose joint, cardiovascular, and neurological needs are growing faster than
Biocompounding May 10, 2026

Subscribe to BioCompounding

Understand the healthcare companies that will compound for a decade. Deep dives for long-term investors who aren’t biologists.
  • Sign up
  • Disclaimer
  • Collaboration & Partnership
BioCompounding © 2026. Powered by Ghost